The first one, accounting for <1% of AD cases, is caused by rare and fully penetrant mutations in three genes: amyloid-β precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2). The gene discussed is APP; the disease is Alzheimer disease.